logo-loader

Full interview: Acasti Pharma receives $750,000 grant from National Research Council of Canada

Published: 13:22 09 Sep 2019 EDT

Acasti Pharma (CVE: ACST) Co-founder COO and Chief Scientific Officer Dr, Pierre Lemieux joined Steve Darling from Proactive Vancouver on Skype to discuss the company has received a sizable grant from the Canadian Government to help their drug development work.

Lemieux telling Proactive what the money will be used for and also an update on the development of CaPre. 

Acasti Pharma outlines key benefits of recent Grace Therapeutics acquisition

Acasti Pharma Inc (TSX-V:ACST, NASDAQ:ACST). CEO Jan D’Alvise joined Proactive New York to discuss the Laval, Québec-based group's recent acquisition of Grace Therapeutics including its therapeutic pipeline consisting of three clinical stage and pre-clinical stage assets. D’Alvise walked...

on 10/08/2021